Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Two-faced protein can stop metastasis or promote it, researchers say
Slashdot It! Slashdot Two-faced protein can stop metastasis or promote it, researchers say
Submit to Reddit Submit Two-faced protein can stop metastasis or promote it, researchers say to Reddit
Reading: Two-faced protein can stop metastasis or promote it, researchers sayTwitter This Reading: Two-faced protein can stop metastasis or promote it, researchers sayTwitter Two-faced protein can stop metastasis or promote it, researchers say
Add to Facebook Add Two-faced protein can stop metastasis or promote it, researchers say to Facebook

Two-faced protein can stop metastasis or promote it, researchers say

September 19, 2006

A protein known to be a key component of the glue that holds cells together also is involved in breaking them apart and promoting their movement when tumors begin to spread to other parts of the body, researchers at Mayo Clinic have found.

The study, published in the Sept. 18 online issue of the Journal of Cell Biology, helps illuminate the very first steps involved in metastasis, the spread of cancer that makes the disease difficult to treat, and suggests that a future designer drug might be able to block the beginning of this dangerous process, or stop it once it starts.




"Our data show that this one protein, p120 catenin, is a key player in both suppressing invasion and promoting it," says the study's senior author, Panos Anastasiadis, Ph.D., a Mayo Clinic cancer researcher. "This is very exciting, because the findings open up a whole new field of discovery for novel therapeutics that should be applicable to most types of tumors."

Their laboratory study looks at how p120 catenin interacts with different cadherin cell adhesion proteins in cancer cells. Cadherin proteins go through a cell membrane, and on the outside, they act like Velcro, sticking to other cadherin proteins on adjacent cells. On the inside of the cell membrane, cadherins bind, chain-like, to catenins, and catenins, in turn, regulate a cell's shape and function.

The best understood cadherin is E-cadherin, which provides tight connections between epithelial cells, forming a strong barrier-like layer covering the inside of organs and body cavities and the outside skin of humans. "E-cadherin holds a human's cells and tissues together," Anastasiadis says.

The other cadherins featured in this study belong to a group that collectively is called "mesenchymal" cadherins, which provide a looser bond between the cells that sparsely populate the connective tissue. "Collagen usually provides the strength to the connective tissue, so tight cell-cell adhesion is not that important," he says.

Sometimes, such as during human development or wound repair, epithelial cells need to travel to other areas, and to do this, they undergo a process known as "epithelial-mesenchymal transition" (EMT). The cell reduces its production of E-cadherin proteins and increases expression of mesenchymal cadherins, thus effectively loosening the anchors that keep the cell bound to its neighbors.

Cancer, unfortunately, has adopted this strategy in order to spread, Anastasiadis says. "When the function of E-cadherin is lost in a cell, it can break free from its neighbors and travel to settle elsewhere," he says. "This means that E-cadherin normally helps suppress invasion."

But researchers have noted that the p120 catenin protein seems mysteriously two-faced: while it normally strengthens cell-cell bonding, in some cases it can also negatively affect cell adhesion. They also have found that over production of p120 increases a cell's ability to move. But the significance of these observations had eluded scientists.

In this study, Masahiro Yanagisawa, M.D., Ph.D., a research fellow in Anastasiadis' laboratory, and Anastasiadis provide an answer as to why p120 acts this way, which helps explain how the EMT shift between E-cadherin and mesenchymal cadherins allows cancer cells to break away from tissue and spread.

They found that p120 "prefers" to bind to E-cadherin, rather than to mesenchymal cadherins. So in normal epithelial cells p120 always associates with the more abundant E-cadherins. But when E-cadherin production is lost during the progression of cancer, p120 catenins begin binding to mesenchymal cadherins. And when that happens, the researchers found that p120 unexpectedly switches on a cascade of events that promote cell movement.

"We show that E-cadherin suppresses invasion, at least in part, by binding to p120 protein in the cell," Anastasiadis says. "If E-cadherin is missing, p120 is free to bind to mesenchymal cadherins, setting off a process that leads to metastasis."

Thus, p120 acts as a "rheostat" that promotes either stability when associated with E-cadherin or motility when it interacts with mesenchymal cadherins, he says.

The investigators say that further research is needed to see if p120 functions the same way in living tissue as it does in laboratory cell culture, and they add that other "pathways" are likely involved in the transition to metastasis. But if the results continue to hold up, "it might be therapeutically possible to selectively shut down the pro-invasive function of p120 on mesenchymal cadherins while keeping the pro-adhesion function of p120 in normal epithelial cells.

"We have provided a better understanding of the processes involved in the initiation of tumor spread, and it is this process that we all seek to shut down,\\\

Mayo Clinic, Jacksonville





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Respiratory Infection   Substance Abuse   Antidepressant   Diamond   Spectroscopy   Chromatin   Quantum Physics   Jellyfish   Clinical Trials   Fibromyalgia   Diet   Influenza Vaccine   Color Vision   Sleep Duration   Acute Lymphoblastic Leukemia   Malaria   Bariatric Surgery   Quantum computer   Electrons   Quantum Mechanics   Drosophila   Cardiac Death   Dengue Virus   Gastric Bypass   Cerebral Palsy  
Related Metastasis Current Events and Metastasis News Articles Metastasis Current Events and Metastasis News RSS Metastasis Current Events and Metastasis News RSS
Newly appreciated membrane estrogen receptor important therapeutic target for breast cancer
New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer.

Predicting the return of prostate cancer: New Johns Hopkins study betters the odds of success
Cancer experts at Johns Hopkins say a study tracking 774 prostate cancer patients for a median of eight years has shown that a three-way combination of measurements has the best chance yet of predicting disease metastasis.

Colorectal cancer
Previously, only a few genes had been associated with the formation of metastases in colorectal cancer. Now, researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch and Charité - University Medicine Berlin, Germany, have identified 115 genes that are disregulated both in the primary tumor and in its metastases.

Like burrs on your clothes, molecule-size capsules can deliver drugs by sticking to targeted cells
It is now possible to engineer tiny containers the size of a virus to deliver drugs and other materials with almost 100 percent efficiency to targeted cells in the bloodstream.

Targeting Tumor Behavior May Lead To New Liver Cancer Drugs
Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior.

New method separates cancer cells from normal cells
The vast majority of cancer deaths are due to metastasis, the spread of cancer cells from its primary site to other parts of the body.

RNA snippet suppresses spread of aggressive breast cancer
A low cellular level of a tiny fragment of RNA appears to increase the spread of breast cancer in mouse models of the disease, according to researchers at Whitehead Institute for Biomedical Research.

NYU Langone Medical Center researchers identify key gene in deadly inflammatory breast cancer
Aggressive, deadly and often misdiagnosed, inflammatory breast cancer (IBC) is the most lethal form of primary breast cancer, often striking women in their prime and causing death within 18 to 24 months.

Prostate cancer test improves prediction of disease course
A new prostate cancer risk assessment test, developed by a UCSF team, gives patients and their doctors a better way of gauging long-term risks and pinpointing high risk cases.

Researchers identify four new targets for breast cancer
Four suspects often found at the scene of the crime in cancer are guilty of the initiation and progression of breast cancer in mice that are resistant to the disease, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in the June edition of Cancer Cell.
More Metastasis Current Events and Metastasis News Articles
Xenakis: Metastasis; Pithoprakta; Eonta

Xenakis: Metastasis; Pithoprakta; Eonta
Iannis Xenakis (Composer), Maurice Le Roux (Composer), Ensemble Instrumental de Musique Contemporaine de Paris (Composer), ORTF National Orchestra (Composer), Yuji Takahashi (Composer), G. Moisan (Composer), J. Toulon (Composer), M. Chapellier (Composer), L. Longo (Composer), Pierre Thibaud (Composer)



Cell Motility in Cancer Invasion and Metastasis (Cancer Metastasis - Biology and Treatment)

Cell Motility in Cancer Invasion and Metastasis (Cancer Metastasis - Biology and Treatment)
by Alan Wells (Editor)

Cancer Morbidity and mortality result from invasive and metastatic spread. Currently, no therapies are aimed at the underlying mechanisms that enable this progression due to only nascent recognition of the distinct biology which occurs only during tumor dissemination. Recent advances have highlighted the central role of cell motility during the dynamic and transient process of tumor invasion and metastasis. This book includes state-of-the-art updates by international leaders in these studies. Chapters first present the novel model systems that enable new investigations and insights. Chapters then describe in depth the key processes and molecules that may be therapeutically targeted. Finally, the role of cell motility and its signals is explored in a number of key tumor types. This...

Metastasis of Breast Cancer (Cancer Metastasis - Biology and Treatment)

Metastasis of Breast Cancer (Cancer Metastasis - Biology and Treatment)
by Springer

Metastasis (spread of cancer in the body) is the main cause of death for patients with breast cancer, the leading female tumour in the industrialised countries and developing countries alike. The biology and treatment of breast cancer metastasis remains an active area of scientific and clinical investigation.

Written by experts in the subject area, the book has covered a broad range of topics in the metastasis of breast cancer, from genetics, biology to clinical management. Main topics include genetic control, biology, growth factors, cell adhesion, cell motility and invasion, natures of bone metastasis, sentinel node therapies, hormonal links, new biomarkers and detection of micrometastasis, and diagnosis The book also covers the current treatment options including surgical...

Metastasis of Breast Cancer (Cancer Metastasis - Biology and Treatment)

Metastasis of Breast Cancer (Cancer Metastasis - Biology and Treatment)
by Robert E. Mansel (Editor), Oystein Fodstad (Editor), Wen G. Jiang (Editor)

Metastasis (spread of cancer in the body) is the main cause of death for patients with breast cancer, the leading female tumour in the industrialised countries and developing countries alike. The biology and treatment of breast cancer metastasis remains an active area of scientific and clinical investigation.

Written by experts in the subject area, the book has covered a broad range of topics in the metastasis of breast cancer, from genetics, biology to clinical management. Main topics include genetic control, biology, growth factors, cell adhesion, cell motility and invasion, natures of bone metastasis, sentinel node therapies, hormonal links, new biomarkers and detection of micrometastasis, and diagnosis The book also covers the current treatment options including surgical...

Lung Cancer: Lung, Non-small cell lung carcinoma, Adenocarcinoma, Metastasis, Lung cancer staging, Dyspnea, Clubbing, Carcinogen, Lambert-Eaton myasthenic syndrome, Health effects of tobacco

Lung Cancer: Lung, Non-small cell lung carcinoma, Adenocarcinoma, Metastasis, Lung cancer staging, Dyspnea, Clubbing, Carcinogen, Lambert-Eaton myasthenic syndrome, Health effects of tobacco
by John McBrewster (Editor), Frederic P. Miller (Editor), Agnes F. Vandome (Editor)

Lung Cancer - Lung, Non-small cell lung carcinoma, Adenocarcinoma, Metastasis, Lung cancer staging, Dyspnea, Clubbing, Carcinogen, Lambert-Eaton myasthenic syndrome, Health effects of tobacco, Carcinogenesis, Lung cancer screening, Interstitial lung disease, Asbestos, Solitary pulmonary nodule, Performance status, Surgery, Chemotherapy, Chronic obstructive pulmonary disease, Spirometry, Pneumonectomy

Metastasis for 61 musicians (1954)

Metastasis for 61 musicians (1954)
by X5 Music Group



Cell Motility in Cancer Invasion and Metastasis

Cell Motility in Cancer Invasion and Metastasis
by Springer

Cancer Morbidity and mortality result from invasive and metastatic spread. Currently, no therapies are aimed at the underlying mechanisms that enable this progression due to only nascent recognition of the distinct biology which occurs only during tumor dissemination. Recent advances have highlighted the central role of cell motility during the dynamic and transient process of tumor invasion and metastasis. This book includes state-of-the-art updates by international leaders in these studies. Chapters first present the novel model systems that enable new investigations and insights. Chapters then describe in depth the key processes and molecules that may be therapeutically targeted. Finally, the role of cell motility and its signals is explored in a number of key tumor types. This...

Introduction to Oncology: Metastasis and Staging

Introduction to Oncology: Metastasis and Staging
by GeneEd E-Learning

This course explains how a cancer can spread through the body and how that metastatic event determines treatment options. eTextBooks from GeneEd are self-paced, multimedia courses designed for nurses (RNs), doctors (MDs and PhDs), clinical research associates (CRAs and monitors), clinical research coordinators (CRCs), investigators, researchers, other healthcare professionals, and patients. Accreditation: GeneEd designates this educational activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education. GeneEd, Inc., is accredited by the Institute for Medical Quality/California Medical...

Bone Metastasis (Cancer Drug Discovery and Development)

Bone Metastasis (Cancer Drug Discovery and Development)
by Gurmit Singh (Editor), Shafaat A. Rabbani (Editor)

A state-of-the-art review of the molecular underpinnings of bone-seeking cancers, current treatment approaches for them, and future therapeutic strategies. The authors illuminate the role of various autocrine, paracrine, and immunological factors involved in the progression and establishment of bone metastases, highlighting the physiological processes that lead to bone degradation, pain, angiogenesis, and dysregulation of bone turnover. They also discuss the various strategies that appear to have promise and are currently deployed in treatment or are at the experimental stage.

Xenakis:Metastasis/Pithoprakta/Eonta

Xenakis:Metastasis/Pithoprakta/Eonta
by Contemporary Music



© 2009 BrightSurf.com